The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Experimental Neurology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2011.11.001PMID 22101005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P3‐157: A novel microRNA interaction relevant to alzheimer's disease pathogenesis and drug target discovery: miR‐346 induces expression of amyloid precursor protein

  2011cited by this paper
• Astrocytic Aβ1‐42 uptake is determined by Aβ‐aggregation state and the presence of amyloid‐associated proteins

  2010cited by this paper
• Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease.

  2010cited by this paper
• Expression and functional profiling of neprilysin, insulin‐degrading enzyme, and endothelin‐converting enzyme in prospectively studied elderly and Alzheimer’s brain

  2010cited by this paper
• MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophages.

  2010cited by this paper
• Amyloid-β Aggregates Cause Alterations of Astrocytic Metabolic Phenotype: Impact on Neuronal Viability

  2010cited by this paper
• Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain.

  2010cited by this paper
• Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

  2010cited by this paper
• Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures

  2010cited by this paper
• Binding and uptake of Aβ1‐42 by primary human astrocytes in vitro

  2009cited by this paper
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

  2009cited by this paper
• Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?

  2009cited by this paper
• Transplanted astrocytes internalize deposited β‐amyloid peptides in a transgenic mouse model of Alzheimer's disease

  2008cited by this paper
• Megalin is a receptor for albumin in astrocytes and is required for the synthesis of the neurotrophic factor oleic acid

  2008cited by this paper
• The AβCs of Aβ-cleaving Proteases*

  2008cited by this paper
• ApoE promotes the proteolytic degradation of Abeta.

  2008cited by this paper
• Cigarette smoke decreases MARCO expression in macrophages: implication in Mycoplasma pneumoniae infection.

  2008cited by this paper
• Oligomer-specific Abeta toxicity in cell models is mediated by selective uptake.

  2008cited by this paper
• Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells.

  2007cited by this paper
• Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System

  2007cited by this paper
• Astrocytes aged in vitro show a decreased neuroprotective capacity

  2007cited by this paper
• Minocycline does not affect amyloid β phagocytosis by human microglial cells

  2007cited by this paper
• Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression.

  2007cited by this paper
• Minocycline does not affect amyloid beta phagocytosis by human microglial cells.

  2007cited by this paper
• Amyloid-beta 1-42 induced endocytosis and clusterin/apoJ protein accumulation in cultured human astrocytes.

  2007cited by this paper
• New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection

  2007cited by this paper
• Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism

  2006cited by this paper
• Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ*

  2006cited by this paper
• Decreased Expression and Activity of Neprilysin in Alzheimer Disease Are Associated With Cerebral Amyloid Angiopathy

  2006cited by this paper
• Clusterin: a protective mediator for ischemic cardiomyocytes?

  2005cited by this paper
• Amyloid associated proteins in Alzheimer's and prion disease.

  2005cited by this paper
• Expression of Scavenger Receptors in Glial Cells

  2005cited by this paper
• ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes

  2004cited by this paper
• ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition: Evidence that ApoE Regulates Extracellular Aβ Metabolism In Vivo

  2004cited by this paper
• Amyloid β plaque-associated proteins C1q and SAP enhance the Aβ1–42 peptide-induced cytokine secretion by adult human microglia in vitro

  2003cited by this paper
• Adult mouse astrocytes degrade amyloid-β in vitro and in situ

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Adult mouse astrocytes degrade amyloid-beta in vitro and in situ.

  2003cited by this paper
• Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo

  2003cited by this paper
• Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.

  2003cited by this paper
• Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer’s Disease Is Associated with the Apolipoprotein E- (cid:1) 4 Allele

  2002cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Megalin and cubilin: multifunctional endocytic receptors

  2002cited by this paper
• Declining Expression of Neprilysin in Alzheimer Disease Vasculature: Possible Involvement in Cerebral Amyloid Angiopathy

  2002cited by this paper
• Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

  2001cited by this paper
• Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain.

  2001cited by this paper
• Effects of the β-Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-α and Matrix Metalloproteinase-9 by Human Monocytic THP-1*

  2001cited by this paper
• α-1-Antichymotrypsin Promotes β-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease

  2001cited by this paper
• Metabolic regulation of brain Abeta by neprilysin.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Metabolic Regulation of Brain Aβ by Neprilysin

  2001cited by this paper
• Apolipoprotein E, Smooth Muscle Cells and the Pathogenesis of Cerebral Amyloid Angiopathy: the Potential Role of Impaired Cerebrovascular Aβ Clearance

  2000cited by this paper
• Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.

  2000cited by this paper
• Molecular characterization of a human scavenger receptor, human MARCO.

  2000cited by this paper
• Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.

  2000cited by this paper
• Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein

  2000cited by this paper
• Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex

  2000cited by this paper
• β-Amyloid Immunoreactivity in Astrocytes in Alzheimer's Disease Brain Biopsies: An Electron Microscope Study

  1999cited by this paper
• beta-Amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study.

  1999cited by this paper
• Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease.

  1999cited by this paper
• Occurrence of the diffuse amyloid β‐protein (Aβ) deposits with numerous Aβ‐containing glial cells in the cerebral cortex of patients with Alzheimer's disease

  1999cited by this paper
• Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.

  1998cited by this paper
• Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10

  1998cited by this paper
• Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation*

  1998cited by this paper
• Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production.

  1998cited by this paper
• Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization

  1997cited by this paper
• Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.

  1997cited by this paper
• Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

  1996cited by this paper
• Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease

  1996cited by this paper
• Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor

  1996cited by this paper
• Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease.

  1996cited by this paper
• Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

  1996cited by this paper
• Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly.

  1995cited by this paper
• The Netherlands brain bank--a clinico-pathological link in aging and dementia research.

  1993cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.

  1991cited by this paper
• Spatial relationships between astrocytes and classical plaque components.

  1991cited by this paper
• SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis.

  1988cited by this paper

• Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective

  2026cites this paper
• Transthyretin, a novel prognostic marker of POCD revealed by time-series RNA-sequencing analysis

  2025cites this paper
• Phytochemicals as modulators of Astrocytes in Alzheimer's disease: A therapeutic perspective.

  2025cites this paper
• Comprehensive Histopathological and Biochemical Analyzes of Prostatic Amyloid Bodies (Corpora Amylacea) From Autopsy Samples From Japanese Patients

  2025cites this paper
• The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer’s Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression

  2025cites this paper
• Vimentin Fragmentation and Its Role in Amyloid-Beta Plaque Deposition in Alzheimer’s Disease

  2025cites this paper
• Atractylenolide III Promotes Astrocyte Aβ Clearance by Up-regulating AQP4 to Improve Alzheimer's Disease.

  2025cites this paper
• Receptor-mediated endocytosis by megalin: Exploring its role in ligand interaction and disease mechanisms

  2025cites this paper
• Astrocytes phenomics as new druggable targets in healthy aging and Alzheimer’s disease progression

  2025cites this paper
• Natural Products as Potential Modulators of Pro-Inflammatory Cytokines Signalling in Alzheimer's Disease

  2024cites this paper
• Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer’s disease

  2023cites this paper
• Aquaporin-4 mediated aggregation of Alzheimer’s amyloid β-peptide

  2023cites this paper
• Mitochondrial calcium uptake 3 mitigates cerebral amyloid angiopathy-related neuronal death and glial inflammation by reducing mitochondrial dysfunction.

  2023cites this paper
• Beclin 1 regulates astrocyte phagocytosis and phagosomal recruitment of retromer.

  2023cites this paper
• Comparison of Brain MRI Findings between Patients with Alzheimer's Disease and Non-Dementia Psychiatric Disorders in the Elderly

  2023cites this paper
• Low Density Lipoprotein Receptor-related Protein 2 Expression and Function in Cultured Astrocytes and Microglia

  2023cites this paper
• Aerobic Exercise Training-Induced Changes on DNA Methylation in Mild Cognitively Impaired Elderly African Americans: Gene, Exercise, and Memory Study - GEMS-I

  2022cites this paper
• Glial Cells in Alzheimer's Disease: From Neuropathological Changes to Therapeutic Implications.

  2022cites this paper
• Ginkgolide B-induced AMPK pathway activation protects astrocytes by regulating endoplasmic reticulum stress, oxidative stress and energy metabolism induced by Aβ1-42

  2021cites this paper
• Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential

  2021cites this paper
• Genetic deletion of α7 nicotinic acetylcholine receptors induces an age-dependent Alzheimer's disease-like pathology.

  2021cites this paper
• Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer's disease pathology

  2021cites this paper
• Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action

  2021cites this paper
• Astrocyte subtype-specific approach to Alzheimer's disease treatment.

  2021cites this paper
• A failure of β-amyloid physiological function due to genetic deletion of α7 nicotinic acetylcholine receptors induces an Alzheimer’s disease-like pathology

  2021cites this paper
• Abstract. Ginkgolide B (GB), the diterpenoid lactone compound isolated from the extracts of Ginkgo biloba leaves, significantly improves cognitive impairment, but its potential pharmacological effect on astrocytes induced by β‐amyloid

  2021cites this paper
• An Aβ3‑10‑KLH vaccine decreases Aβ plaques and astrocytes and microglia activation in the brain of APP/PS1 transgenic mice.

  2021cites this paper
• Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques

  2021cites this paper
• NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer’s Disease

  2021cites this paper
• Traumatic Injury Reduces Amyloid Plaque Burden in the Transgenic 5xFAD Alzheimer’s Mouse Spinal Cord

  2020cites this paper
• Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia.

  2020cites this paper
• Anodal Transcranial Direct Current Stimulation Can Improve Spatial Learning and Memory and Attenuate Aβ42 Burden at the Early Stage of Alzheimer’s Disease in APP/PS1 Transgenic Mice

  2020cites this paper
• Inflammation: A Major Target for Compounds to Control Alzheimer's Disease.

  2020cites this paper
• Inflammatory Cytokine IL-1β Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing.

  2020cites this paper
• Human iPSC-derived astrocytes transplanted into the mouse brain display three morphological responses to amyloid-β plaques

  2020cites this paper
• Danger-Sensing/Patten Recognition Receptors and Neuroinflammation in Alzheimer’s Disease

  2020cites this paper
• Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors

  2019cites this paper
• Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms

  2019cites this paper
• ASTROCYTES AND THEIR ROLE IN THE PATHOLOGY OF THE CENTRAL NERVOUS SYSTEM

  2019cites this paper
• Neurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy

  2019cites this paper
• Neuroinflammation as a Common Feature of Neurodegenerative Disorders

  2019cites this paper
• Inflammation, insulin signaling and cognitive function in aged APP/PS1 mice.

  2018cites this paper
• The Biology of Glial Cells and Their Complex Roles in Alzheimer’s Disease: New Opportunities in Therapy

  2018cites this paper
• A&bgr;‐oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti‐A&bgr; single chain variable fragment in combination with an apoE mimetic peptide

  2018cites this paper
• Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.

  2018influential citation
• Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective

  2017cites this paper
• Oleocanthal ameliorates amyloid-β oligomers' toxicity on astrocytes and neuronal cells: In vitro studies.

  2017cites this paper
• Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition

  2017cites this paper
• The Anti-Inflammatory Effects of Lipoxygenase and Cyclo-Oxygenase Inhibitors in Inflammation-Induced Human Fetal Glia Cells and the Aβ Degradation Capacity of Human Fetal Astrocytes in an Ex vivo Assay

  2017cites this paper
• Calcium-Sensing Receptor Antagonist NPS 2143 Restores Amyloid Precursor Protein Physiological Non-Amyloidogenic Processing in Aβ-Exposed Adult Human Astrocytes

  2017cites this paper
• The Association of MME microRNA Binding Site Polymorphism with the Risk of Late Onset Alzheimer's Disease in Northern Han Chinese.

  2017cites this paper
• Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

  2017cites this paper
• β-amyloid increases neurocan expression through regulating Sox9 in astrocytes: A potential relationship between Sox9 and chondroitin sulfate proteoglycans in Alzheimer's disease.

  2016cites this paper
• Glial Cells - The Key Elements of Alzheimer´s Disease.

  2016cites this paper
• Implication du remodelage de l'unité neurovasculaire dans la maladie d'Alzheimer : l'hypoperfusion cérébrale et le système de l'activateur tissulaire du plasminogène

  2016influential citation
• Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

  2016influential citation
• Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease

  2016cites this paper
• POTENTIAL APPROACHES FOR REDUCING AMYLOID β PRODUCTION.

  2016cites this paper
• Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection.

  2016cites this paper
• Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan

  2016cites this paper
• Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease.

  2016cites this paper
• Inhibitory Effect of Memantine on Streptozotocin-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Neurotrophic Factor Decline in Astrocytes

  2016cites this paper
• Utjecaj inhibitora monoaminooksidaze A i B na fosforilaciju proteina tau - terapijski učinak u Alzheimerovoj bolesti

  2015cites this paper
• Alzheimer's disease, astrocytes and kynurenines.

  2015cites this paper
• Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme

  2015cites this paper
• Cholesterol‐induced astrocyte activation is associated with increased amyloid precursor protein expression and processing

  2015cites this paper
• Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer’s Disease Biology: Characterization of Putative Cognates for Therapeutic Applications

  2015cites this paper
• Synergistic Actions of Microglia and Astrocytes in the Progression of Alzheimer's Disease

  2015cites this paper
• Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes

  2015cites this paper
• Age, inflammation and Abeta itself influence Abeta degradation in Alzheimer's Disease

  2014cites this paper
• The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders

  2014cites this paper
• Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: Insights from proteomics

  2014cites this paper
• Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure.

  2014cites this paper
• Neprilysins: An Evolutionarily Conserved Family of Metalloproteases That Play Important Roles in Reproduction in Drosophila

  2014cites this paper
• Mechanisms of U87 Astrocytoma Cell Uptake and Trafficking of Monomeric versus Protofibril Alzheimer’s Disease Amyloid-β Proteins

  2014cites this paper
• Microglial Aβ Receptors in Alzheimer’s Disease

  2014cites this paper
• ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.

  2014cites this paper
• When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.

  2014cites this paper
• Apolipoproteins E and J interfere with amyloid‐beta uptake by primary human astrocytes and microglia in vitro

  2014cites this paper
• Chronic airway-induced allergy in mice modifies gene expression in the brain toward insulin resistance and inflammatory responses

  2013cites this paper
• Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease

  2013cites this paper
• Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?

  2013cites this paper
• 3H-Deprenyl and 3H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brain

  2013cites this paper
• Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.

  2013cites this paper
• Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.

  2013cites this paper
• Neprilysin-Like Activity Correlates with CSF-Tau and Phospho-Tau in Patients with Alzheimer's Disease

  2013cites this paper
• Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

  2013cites this paper
• Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease.

  2013cites this paper
• Involvement of formyl peptide receptors in receptor for advanced glycation end products (RAGE) - and amyloid beta 1-42-induced signal transduction in glial cells

  2012influential citation
• The Relationship Between Astrocyte-mediated Metabolism of β-Amyloid Protein and Pathogenesis of The Early Stages of Alzheimer′s Disease*: The Relationship Between Astrocyte-mediated Metabolism of β-Amyloid Protein and Pathogenesis of The Early Stages of Alzheimer′s Disease*

  2012cites this paper
• Diabetes exacerbates amyloid and neurovascular pathology in aging‐accelerated mice

  2012influential citation
• The role of astrocytes in amyloid β-protein toxicity and clearance.

  2012cites this paper
• Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau

  2012cites this paper
• Role of Neprilysin in The Pathogenesis of Alzheimer′s Disease*: Role of Neprilysin in The Pathogenesis of Alzheimer′s Disease*

  2012cites this paper
• Radiology and Imaging Technology

  year unknowncites this paper
• Inflammation: A Major Target for Compounds to Control Alzheimer’s Disease

  year unknowncites this paper